# A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

> **NCT01715909** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 20 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT01715909
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-22
- **Primary completion:** 2018-06-17
- **Final completion:** 2018-06-17
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715909, "A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01715909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*